672 related articles for article (PubMed ID: 18570244)
1. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
Hou W; Chen L; Yang G; Zhou H; Jiang Q; Zhong Z; Hu J; Chen X; Wang X; Yuan Y; Tang M; Wen J; Wei Y
Phytother Res; 2008 Aug; 22(8):1125-32. PubMed ID: 18570244
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
[TBL] [Abstract][Full Text] [Related]
3. Improved therapeutic efficacy against murine carcinoma by combining honokiol with gene therapy of PNAS-4, a novel pro-apoptotic gene.
Yuan Z; Liu H; Yan F; Wang Y; Gou L; Nie C; Ding Z; Lai S; Zhao Y; Zhao X; Li J; Deng H; Mao Y; Chen L; Wei Y; Zhao X
Cancer Sci; 2009 Sep; 100(9):1757-66. PubMed ID: 19575751
[TBL] [Abstract][Full Text] [Related]
4. Honokiol, a phytochemical from Magnolia spp., inhibits breast cancer cell migration by targeting nitric oxide and cyclooxygenase-2.
Singh T; Katiyar SK
Int J Oncol; 2011 Mar; 38(3):769-76. PubMed ID: 21225228
[TBL] [Abstract][Full Text] [Related]
5. [Effects of honokiol on proliferation and apoptosis of human cervical carcinoma cell line Hela in vitro].
Yang GL; Hou WL; Fu AF; Zhong ZH; Yin XH; Chen LJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):558-62. PubMed ID: 18798493
[TBL] [Abstract][Full Text] [Related]
6. Honokiol induces cell apoptosis in human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress.
Chen YJ; Wu CL; Liu JF; Fong YC; Hsu SF; Li TM; Su YC; Liu SH; Tang CH
Cancer Lett; 2010 May; 291(1):20-30. PubMed ID: 19880244
[TBL] [Abstract][Full Text] [Related]
7. Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma.
Stover TC; Sharma A; Robertson GP; Kester M
Clin Cancer Res; 2005 May; 11(9):3465-74. PubMed ID: 15867249
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol.
Xu D; Lu Q; Hu X
Cancer Lett; 2006 Nov; 243(2):274-80. PubMed ID: 16406853
[TBL] [Abstract][Full Text] [Related]
9. Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells.
Li Z; Liu Y; Zhao X; Pan X; Yin R; Huang C; Chen L; Wei Y
Eur J Obstet Gynecol Reprod Biol; 2008 Sep; 140(1):95-102. PubMed ID: 18440692
[TBL] [Abstract][Full Text] [Related]
10. Anticancer activity of litchi fruit pericarp extract against human breast cancer in vitro and in vivo.
Wang X; Yuan S; Wang J; Lin P; Liu G; Lu Y; Zhang J; Wang W; Wei Y
Toxicol Appl Pharmacol; 2006 Sep; 215(2):168-78. PubMed ID: 16563451
[TBL] [Abstract][Full Text] [Related]
11. Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo.
Hsu YL; Kuo PL; Tzeng TF; Sung SC; Yen MH; Lin LT; Lin CC
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e290-9. PubMed ID: 18522681
[TBL] [Abstract][Full Text] [Related]
12. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
Hahm ER; Arlotti JA; Marynowski SW; Singh SV
Clin Cancer Res; 2008 Feb; 14(4):1248-57. PubMed ID: 18281560
[TBL] [Abstract][Full Text] [Related]
13. Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors.
Leeman-Neill RJ; Cai Q; Joyce SC; Thomas SM; Bhola NE; Neill DB; Arbiser JL; Grandis JR
Clin Cancer Res; 2010 May; 16(9):2571-9. PubMed ID: 20388852
[TBL] [Abstract][Full Text] [Related]
14. Honokiol induces paraptosis and apoptosis and exhibits schedule-dependent synergy in combination with imatinib in human leukemia cells.
Wang Y; Yang Z; Zhao X
Toxicol Mech Methods; 2010 Jun; 20(5):234-41. PubMed ID: 20374036
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of therapeutic effectiveness by combining liposomal honokiol with cisplatin in ovarian carcinoma.
Liu Y; Chen L; He X; Fan L; Yang G; Chen X; Lin X; DU L; Li Z; Ye H; Mao Y; Zhao X; Wei Y
Int J Gynecol Cancer; 2008; 18(4):652-9. PubMed ID: 17892458
[TBL] [Abstract][Full Text] [Related]
16. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X
Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
[TBL] [Abstract][Full Text] [Related]
17. A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes.
Liu Y; Lu WL; Guo J; Du J; Li T; Wu JW; Wang GL; Wang JC; Zhang X; Zhang Q
J Control Release; 2008 Jul; 129(1):18-25. PubMed ID: 18466993
[TBL] [Abstract][Full Text] [Related]
18. Honokiol induces apoptosis via cytochrome c release and caspase activation in activated rat hepatic stellate cells in vitro.
Park EJ; Zhao YZ; Kim YH; Lee BH; Sohn DH
Planta Med; 2005 Jan; 71(1):82-4. PubMed ID: 15678380
[TBL] [Abstract][Full Text] [Related]
19. [Experimental study on antitumor effects of Shen Qi Jin Kang (SQJK)].
Liu ZY; Wang DC; Fu ZD; Liu HY; Liang Z; Cheng DW; Liang JL; Liang JM
Ai Zheng; 2006 Aug; 25(8):983-9. PubMed ID: 16965679
[TBL] [Abstract][Full Text] [Related]
20. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
